The signs of progression of Mutliple Sclerosis are often barely detectable. Even if MRIs don't show new lesions, disability can worsen through symptoms such as fatigue, difficulty multitasking, challenges with dexterity, and muscle spasms. In one of our webinars - available as a course on MS Nurse Pro - Piet Eelen discusses how to detect these subtle signs and proposes improvements for more efficient treatment. Click here to read the article version of his session!
During the 2025 ECTRIMS Conference, MS Nurse Pro had the pleasure of hosting two nurse sessions, the second one focusing on shared decision-making, patient decision aids and digitalisation in MS treatment, especially the use of Artificial Intelligence.
During the 2025 ECTRIMS Conference, MS Nurse Pro had the pleasure of hosting two nurse sessions, the first one focusing on health literacy and patient activation. Health literacy is a fundamental building block for caring for patients with MS. Currently, this covers multiple areas such as digital and vaccine literacy. Click on read more if you want to learn all about health literacy, patient activation, and how it can contribute to effective treatment!
Fatigue, cognitive challenges, bladder issues… MS affects daily life in complex ways, yet many symptoms go unaddressed. Discover what over 17,000 people with MS told us in the IMSS survey and why nurses are key to bridging these care gaps. Click to learn practical strategies to improve symptom management and enhance quality of life for people with MS.
Multiple sclerosis (MS) is 3 times more common among women than men and is more common among women of childbearing age than in any other age group. Caring for women with MS requires a comprehensive approach to management across a range of unique issues including family planning decisions, hormonal changes, and reproductive health.
Empower patients with MS-Selfie, a resource by MS expert Prof. Gavin Giovannoni, offering guidance on treatment, switching decisions, and informed care management.
Upcoming 2024 revisions to the McDonald criteria will integrate new MRI technologies and biomarkers, such as neurofilament light chain and the central vein sign, to enable earlier and more accurate MS diagnoses, including in individuals previously classified as having radiologically isolated syndrome.
Explore new findings reporting how vaccinations do not increase the risk of MS in children and adolescents and how urinary tract infections are the leading cause of hospital admissions for people with MS, underscoring the need for improved bladder care and outpatient management strategies.
Explore the latest research insights for MS nurses, covering key advancements in MS management. Highlights include the potential of high-dose vitamin D to delay early MS progression, the impact of disease-modifying treatments on slowing disability in RRMS, and findings from the MS-STAT2 trial on simvastatin’s limitations in SPMS. Stay informed with these evidence-based updates to enhance patient care.
Multiple sclerosis (MS) can significantly impact sexual health, with 40-80% of women and 50-90% of men with MS reporting sexual concerns. Challenges may arise from direct neurological effects, disease symptoms, or psychological and social factors.
Significant progress has advanced our understanding of NMOSD and MOGAD. This 30-minute microlearning covering key features, diagnostic criteria, and emerging therapies, enabling better differentiation from MS will be launch in January 2025.
Hematopoietic stem cell transplantation (HSCT), Bruton's tyrosine kinase (BTK) inhibitors and chimeric antigen receptor (CAR) T-cell therapies are three potential future MS therapies currently under investigation. Read more about latest developments in this blogpost.
It is important for MS Nurses to have a good understanding of generics and biosimilars, including what they are and how they are approved by regulatory agencies, and to have confidence in discussing these with PwMS as they are likely to become an increasing part of clinical practice moving forward.
Course 1 on Understanding MS and Course 2 on the Clinical Presentation of MS have been renewed!
Enroll to our Foundation Programme on MS Nursing available in the Catalogue to check it out!
ChatGPT vs. neurologist: what do patient prefer? High efficacy treatment in paediatric-onset MS to significantly reduce disability progression. Updated guidance on cladribine for aggressive RRMS. PwMS with cognitive impairment tend to report a worse quality of life compared to PwMS without it.
